A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19  − 9 (CA19-9) is limited. There...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Tags: Research Source Type: research